Market research
93M.F MPH Health Care AG
F EUR Healthcare
Latest close
Loading market data…
Test a moving-average rule with historical data.
- Market cap
- 11M
- P/E ratio
- 10.08
- Analyst target
- 8.35
- Dividend yield
- 7.3%
- Beta
- 0.88
Profile
Company facts
- Exchange
- F
- Currency
- EUR
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- ISIN
- DE000A0L1H32
- Market cap
- 11M
- P/E ratio
- 10.08
- Analyst target
- 8.35
- Dividend yield
- 7.3%
- Beta
- 0.88
About
About MPH Health Care AG
MPH Health Care AG operates in the healthcare market in Germany. It produces medicinal products for the therapies of cancer, HIV, and other chronic diseases. The company also offers medical aesthetic treatments; and develops and sells pharmaceutical and medical products, and provides related services, as well as medical devices for the aesthetic surgery and cosmetic dermatology. In addition, it is involved in the provision of cytostatic admixture and concomitant medications; and real estate activities. The company was formerly known as MPH Mittelständische Pharma Holding AG and changed its name to MPH Health Care AG in 2017. MPH Health Care AG was founded in 2008 and is based in Berlin, Germany. MPH Health Care AG operates as a subsidiary of Magnum AG.
Visit company websiteCommunity
Investor discussion
1 comment
Sign in to join the 93M.F discussion.
5 years, 5 months ago
MPH Health Care AG is currently in a long term downtrend where the price is trading 83.2% below its 200 day moving average.
From a valuation standpoint, the stock is 98.8% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 15.6.
Based on the above factors, MPH Health Care AG gets an overall score of 1/5.